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Abstract
SPECIFIC AIMS: To evaluate the current rates of depression screening using the PHQ-2/9 in
patients with comorbid conditions at a single, urban primary care office; to explore barriers to
depression screening among providers.
METHODS: A retrospective chart review was completed on a sample of 188 patients seen
between January and June 2017. Patients were equally divided among four comorbid diagnosesCOPD, obesity, hypertension, and type 2 diabetes. A provider interview was conducted to
identify depression screening barriers and typical treatments regimens.
RESULTS: A total of 70.2% of patients had a documented depression screening. Of 67 patients
diagnosed with depression, 11.9% had follow up specific to depression, 13.4% had
documentation of side effects education, and 19.4% received further mental health services.
Among the comorbid groups there was no difference in the rate or degree of depression.
Diabetic patients with depression had higher hemoglobin A1C levels than those with diabetes
and no depression (p=0.00). Provider interviews identified the following barriers to depression
screening: time constraints, difficulty with patients not following up, and lack of
access/timeliness for mental health services.
CONCLUSION: In this clinic depression screening rates were above the average reported in the
literature. Patients with diabetes were found to be at risk for worsening hemoglobin A1C levels
with depression. There is a need for increased education regarding medications and timelier
follow-up. Barriers still exist in completing screening and initiating treatment and referral to
mental health services. An electronic medical record alert would be helpful in reminding
providers to screen.
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Introduction
Depression, characterized by an overwhelming feeling of sadness or loss of pleasure in
usual activities, is one of the most common mental health disorders in the world (Anxiety and
Depression Association of America, 2016). In 2015, over 16 million adults in the United States
experienced a debilitating episode of major depression (National Institutes of Health, 2015).
Evidence has demonstrated that people with chronic conditions, such as diabetes or
cardiovascular disease, are three to four times more likely to experience depression or other
mental health problems (Naylor et al., 2012). An assessment of current practice will determine if
further measures need to be implemented to improve the rate of depression screening and
treatment in adults with comorbid conditions. The purpose of this study was to evaluate current
depression screening rates in a primary care setting and identify barriers to depression screening
and treatment.
Background
In the United States, depression is set to become the second leading cause of disability by
the year 2020 (Centers for Disease Control, 2013). Depression affects approximately five to
thirteen percent of patients in the primary care setting and accounts for more than $43 billion in
medical costs and $17 billion in lost productivity annually (Maurer, 2012). Depression is often
not adequately treated and, even when it is, depression symptoms recur in up to seventy five
percent of patients. Depression also leads to poorer outcomes in patients with various
comorbidities, such as diabetes mellitus, cardiovascular disease, and obesity (Maurer, 2012).
Without adequate screening, estimates show that only fifty percent of patients with depression
are identified. Due to the frequent stigmatization that accompanies mental health disorders,
many patients will suppress symptoms of depression or are not fully able to recognize what is
2
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causing their mood changes (Gerontoukou, Michaelidoy, Rekleiti, Saridi, & Souliotis, 2015).
Earlier identification and treatment of depression in patients can lead to increased compliance
with medical care, reduction in comorbidities and costs associated with care, and improved
clinical outcomes.
The United States Preventative Services Task Force (USPSTF) has made specific
evidence-based recommendations for depression screening in the adult population to identify
those affected in a more timely manner. Noted as a Grade B recommendation, the USPSTF
recommends depression screening in the general adult population. There is little evidence to
support optimal timing for screening, therefore, the USPSTF suggests a pragmatic approach of
screening all who have not been previously screened or using clinical judgement in consideration
of risk factors and life events. Screening should be implemented with adequate systems in place
to ensure accurate diagnosis, effective treatment, and appropriate follow-up (Siu & USPSTF,
2016).
Multiple depression screening tools are available to fit a wide range of patients, however
this study will focus on the Patient Health Questionnaire-2/9 (PHQ-2/9). The PHQ-2/9 is a selfadministered tool of 2 or 9 items that assesses the frequency of depressed mood and anhedonia
over the past two weeks. Scores range from 0-27 and identify the severity of depression as none
(0-4), mild (5-9), moderate (10-14), moderately severe (15-19), or severe (20-27; Bienenfield,
2016). The PHQ-2/9 is shown to have slightly higher sensitivity and specificity for detecting
depression (97% sensitivity/67% specificity) when compared to other screening tools and is also
more useful for monitoring response to treatment (Maurer, 2012).
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Literature Review
A comprehensive review using the search tool InfoKat Discovery, which includes
popular healthcare databases like CINAHL, PubMed, Ovid, and MEDLINE, was conducted to
assess the effect of depression on patients with comorbidities. Search terms included
“depression”, “depression screening”, “primary care”, “comorbidities”, and “randomized
controlled trial (RCT)”. Inclusion criteria encompassed articles that were: written in English,
available in full text, were published in the last five years, were peer-reviewed, and were RCT’s.
Qualitative or case studies, studies on patients under the age of eighteen, and studies conducted
outside of the United States were excluded. Of the 919 available articles, many were reviewed
until the point of information saturation was reached.
Based on the relevant studies, it seems clear that depression rates are significantly higher
in patients with comorbidities. This is associated with increased mortality, poorer health
outcomes, and decreased quality of life and functional status (Park, Katon, & Wolf, 2013).
Evidence also shows that depression in patients with comorbidities is associated with decreased
compliance with care, more frequent hospitalizations, and increased length of stay, leading to
increased healthcare costs (Pumar et al., 2014). In order to reduce these negative effects, current
research supports the importance of earlier identification of depression in patients with
comorbidities (Stoop, Nefs, Pommer, Pop, & Pouwer, 2015).
Reviewed studies were all Level I or Level II studies per the Johns Hopkins Nursing
Evidence-Based Practice model, which provide the highest level of quality for evidence-based
practice (Ryan et al., 2017). Most study designs included large sample sizes and employed
adequate randomization and blinding. Rigor of data was strong and confounding variables were
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controlled using strict methods and measurement practices. Findings were statistically
significant and efforts were made to reduce limitations in a majority of reviewed studies.
Although the literature confirms the harmful effects of depression amongst those with
comorbidities, there are still flaws in the available research. Available data are somewhat limited
and there is no true consensus on the approach to depression screening and the benefits of
treatment in those with comorbidities (Pumar et al., 2014). More high quality studies are needed
to enhance screening and treatment in relation to chronic disease management. Further studies
are needed to more strongly support USPSTF recommendations and fill knowledge gaps with
regard to the benefits of earlier diagnosis and treatment outcomes in the comorbid population
(Thombs, Ziegelstein, Roseman, Kloda, & Ioannadis, 2014).
Purpose
The purpose of this study was to evaluate the current rates of depression screening and
treatment in patients with comorbidities (COPD, obesity, hypertension, or type 2 diabetes) at a
single Norton Healthcare primary care office. This study aimed to assess the percentage of
patients who are being screened for depression by primary care practitioners in accordance with
current depression screening recommendations for the adult population. Demographic variables
were examined to explore their relationship to depression. The study also examined other
variables including family history of depression, screening tool used, years diagnosed with
depression, depression medications and side effects, follow-up visits, and body mass index,
blood pressure, and hemoglobin A1C measurements.
Methods
This study was a retrospective chart review of patients seen at a single primary care
office location. Patients with a diagnosis of COPD, obesity, hypertension, and/or diabetes were
5
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targeted for the chart review. Included was an interview amongst providers to assess for any
potential barriers to depression screening and treatment in current practice. Approval was given
by the University of Kentucky Institutional Review Board (IRB) and the Norton Healthcare
Office of Research and Administration (NHORA). Consent for chart review was waived as there
was no active participation on behalf of the subjects, whose rights and welfare were protected
under the Health Insurance Portability and Accountability Act (HIPAA).
Setting
Norton Healthcare is the leading healthcare provider in the Louisville, KY area (Norton
Healthcare, 2017). This study population consisted of patients who were seen by a primary care
provider at NCMA Lakeview between the months of January and June in 2017. NCMA
Lakeview is one of several primary care locations within the Norton Healthcare system. This
practice, located on the east side of Louisville, consists of four medical doctors and two nurse
practitioners who provide comprehensive primary care and endocrinology services. This site
was chosen based on clinic interest and the high volume of type 2 diabetic patients seen at this
office.
Sample
Inclusion criteria consisted of adult patients over the age of eighteen years diagnosed
with one or more comorbidities that included obesity, hypertension, type 2 diabetes, and chronic
obstructive pulmonary disease (COPD; see Table 1 for a list of ICD-10 diagnosis codes used for
inclusion criteria). Patients were seen in January through June of 2017. Exclusion criteria were
non-English speaking patients and those under the age of eighteen years. The charts were
randomized from a selection of 4036 medical records provided by data analysts that met criteria
for review. Fifty medical records were obtained from patients in three different comorbid
6
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categories; obesity only; obesity and hypertension; and obesity, hypertension, and type 2
diabetes. Of the patients with COPD only, 38 patients met the criteria for review, bring the total
number of study participants to 188.
For the provider interview, inclusion criteria were status as a primary care provider at
NCMA Lakeview and willingness to participate in the survey. The only exclusion criteria for
providers was a lack of willingness to participate in the interview. Half of the providers (3/6)
participated in the interview; one provider declined to participate and two others were not
available.
Data Collection
Approval was obtained through the University of Kentucky IRB and the Norton
Healthcare Office of Research and Administration (NHORA) prior to data collection. The
medical records for the retrospective chart review were obtained from the electronic database of
patients seen at the NCMA Lakeview office. Charts were identified using the ICD-10 codes
listed in Table 1. Charts were randomly selected to provide an equal representation for patients
with each comorbid condition of interest. For the data collection process patient records were
accessed through EPIC, Norton Healthcare’s electronic medical records system, and data were
abstracted according to the variables listed in Table 2. The data were then transferred to a
password-protected electronic spreadsheet. A crosswalk table was developed to link the medical
record number to a unique patient study number, and this was stored in a separate, secure
location from the abstracted data. Interview responses were transcribed by the PI during a brief,
in-person interview with willing providers.
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Data Analysis
Univariate and bivariate statistics were used to describe the demographic characteristics
of the sample patients. These included parametric independent t-tests with means and standard
deviations for continuous variables and frequency distributions for nominal variables. When
comparing two nominal variables, nonparametric chi-square tests of association were used to
assess the relationship between the two variables. All tests were conducted using SPSS Version
23 and an alpha level of p<0.05 was used to determine statistical significance. Provider
interviews were analyzed for common themes.
Results
Sample Characteristics
A total of 188 patient charts were reviewed. Patients ranged in age from 22 years to 94
years, with a mean age of 57.6 years. A large majority of patients were Caucasian (87.8%), and
over half were female (60.1%). In total 70.2% (n=132) of patients had documented depression
screening using the PHQ-2/9 tool. A documented family history of depression was noted in
10.1% (n=19) of the sample. The PHQ-2/9 was the screening tool used in 100% of the cases
with documented depression screening in the medical record. No other depression screening
tools were used. Demographic and clinical characteristics of the study sample can be seen in
Table 3.
A statistical comparison of patient variables was explored between the screened (n=132)
and non-screened group (n=56). Using chi-square tests of association, the only significant
differences between the groups was in the “age” category. Those above the age of 59 were
found more likely to be screened for depression (p=0.03), but the differences were not clinically
significant. No other statistically significant differences in depression screening rates were
8
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found in any of the other variable groups based on gender, ethnicity, or family history. Results
from the chi-square tests can be seen in Table 4.
Of the 132 patients who were screened for depression, 51% (n=67) were diagnosed with
depression based on screening results (PHQ score of five or greater). Using chi-square tests of
association among those with and without depression diagnosis, significant differences were
found based on ‘gender’ and ‘family history’. Of the 67 patients with depression, 84% were
female (n=56), and 16% were male (n=11), while the non-depressed group was more evenly split
at 47% female (n=57) and 53% male (n=64). This is statistically significant with a p-value of
0.000. Of the 67 patients diagnosed with depression, 18% (n=12) had a family history of
depression, while just 6% of those without depression had a positive family history (p=0.017).
There were no significant differences for gender within each comorbid diagnosis. The
demographics of those diagnosed with depression is presented in Table 5.
In terms of follow-up for their depression (n=67), only 12% had a follow up visit specific
to the diagnosis. However, 48% did have an unrelated office visit within 4-8 weeks where
medication and follow-up to the depression diagnosis were discussed in addition to their primary
concern. There was documentation of medication adjustment or effective dose in 40% (n=27) of
depressed patients. Similarly, only 13% (n=9) of those with depression had documentation of
depression education or the potential side effects of depression medication. Referral to mental
health care services was provided to 19% (n=13) of the group. These frequencies are
documented in Table 6.
Within the patient group diagnosed with depression (n=67), comparisons were made
between the comorbidities (COPD, obesity, hypertension, and type 2 diabetes). There was no
statistically significant difference in the distribution of depression diagnosis among the
9
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comorbidities. Nor was there any statistical difference in the severity of depression. The
average PHQ-2/9 score among those diagnosed with depression was 7.6, which classified a
majority of patients with ‘mild’ depression.
Comparing within each comorbid condition, the patients with and without depression
were evaluated to identify differences in their biometrics (BMI, blood pressure, and hemoglobin
A1C). Among all the comorbid conditions there were no statistically significant differences
except among those with type 2 diabetes. In independent t-tests, hemoglobin A1C levels were
significantly lower in those diagnosed with depression (p=0.00). The mean A1C in the
depressed group was 6.5; in the non-depressed group the mean A1C was 7.87. There were no
statistically significant differences noted among obese or hypertensive patients in conjunction
with depression diagnosis or treatment. Results of the t-tests can be seen in Table 7.
Provider Interviews
Three out of six total provider interviews were completed (see Appendix for the
interview guide). Those responding reported using the PHQ-2/9 screening tool most often as it is
readily available in EPIC and easy to use. They also felt that an electronic medical record
(EMR) alert would aid in recognizing the need for depression screening. Efforts were made to
screen every patient but some screenings were missed due to time constraints or acute visit
status. Follow-up was often hampered due to patient cancellations and no-shows for scheduled
mental health appointments.
In general, each provider described a similar practice in screening, treatment, and followup for depression. For example, they described the primary use of medications such as selective
serotonin/norepinephrine reuptake inhibitors (SSRI/SNRI’s) that coincide with current
guidelines. When deciding to refer a patient for mental health care, determining factors were
10
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patient willingness, insurance, severity of symptoms, and ability to provide timely and accessible
mental health care services. They also agreed that an improved database of mental health
services would be beneficial to themselves and to patients.
Discussion
As depression can often be present for up to three years prior to being identified,
depression screening is essential to earlier identification and treatment (Beblo et al., 2012). The
mental health of patients is an important aspect of primary care, especially in patients with
comorbidities (Kang et al., 2015). By recognizing and adequately treating depression, providers
can work towards better outcomes in patient health. This project has identified the need for
increased patient education, more thorough follow-up, and a better integration with mental health
services.
The demographic distribution of the study sample is representative of the geographical
location of the study site. The project site is located in the east end of Louisville in an aging,
predominately Caucasian area of the city. At this location, women were diagnosed with
depression more frequently than men at a ratio of 5:1. This is consistent with current evidence
that women are more than twice as likely to experience depression (Mayo Clinic, 2016). Yet the
sample for this project included more women than men, which may have skewed these results.
The PHQ-2/9 was the primary screening tool used. Use of this tool by the providers
could be attributed to ease of use and availability as it is the primary screening tool in the EPIC
computer system. Some patients were screened using the PHQ-2/9 multiple times within a year,
not in relation to depression diagnosis or reason for visit. This could demonstrate some overuse
and may result in either overtreatment or responder fatigue. Recommendations indicate
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completing a yearly screen for those without documented depression or more frequently for
those being treated for depression (New York Department of Health, 2016).
Several documentation issues were noted from the chart review. Fewer than 15% of
patients with depression had documentation regarding the timeline of diagnosis. The timeframe
allows providers to identify past treatments, recognize the severity of depression, and have a
more complete clinical history of the patient. Not only will entering the full history populate the
EMR for future visits, it will also help patients feel that their history is important.
Family history of depression was noted in only 10% of the entire surveyed group. There
have been several genetic markers linked to depression and those with a first-degree relative
diagnosed with depression are more than three times as likely to develop depression themselves
(Ledford, 2015). A well-documented family history can alert providers that the patient may have
a predisposition for depression. One consideration is that the burden of stress from living with
the moods and behaviors of a family member with depression can increase one’s likelihood for
developing the condition themselves.
Per American Psychiatric Association (APA) guidelines, it is necessary to follow-up
within four to eight weeks to assess the response to medication and any potential side effects
(APA, 2010). A depression specific follow-up visit post diagnosis or initiation of medication
was evident for 12% of the patients. An additional 48% of patients had visits for an episodic
complaint during the recommended time frame for follow-up where depression and medications
were discussed, however it would be hard to classify this as a true follow-up visit. The need to
increase visits specifically for depression follow-up is present. The National Committee for
Quality Assurance reports that only about 25% of patients receive follow-up in an adequate
timeframe (National Committee for Quality Assurance, 2017).
12
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Unfortunately, only 13% of patients had any documentation of medication side effect
education. Yet, up to 43% of patients discontinue medications for depression due to adverse
effects, most commonly headaches, nausea and vomiting, agitation, sedation, and sexual
dysfunction (Anderson, Pace, Libby, West, & Valuck, 2012). Patient education regarding
potential side effects and the necessity of follow-up visits can help maintain compliance and
achieve the most optimal therapeutic benefit from treatment. It is possible that education was
simply not recorded. Thorough documentation is crucial in patient care, not only because it
validates that adequate care was provided, but it also benefits subsequent caregivers and helps in
the coding and billing process.
Comparisons between the comorbidities (COPD, obesity, hypertension, type 2 diabetes)
showed no significant differences in the rate or degree of depression. This finding is not
congruent with the literature reviewed, in which type 2 diabetics have slightly higher rates of
depressive symptoms (Andreoulakis, Hyphantis, Kandylis, & Iacovides, 2012). This
discrepancy may be due to this study’s smaller sample size and/or the lack of correlation to the
extent of the disease state. In this project the comorbid conditions were not fully evaluated.
Neither the number of complications from the comorbidity nor the extent of the treatment plan
was considered.
One interesting finding was the difference in hemoglobin A1C levels between patients
with diabetes who were depressed and on treatment versus those without depression. This
coincides with the American Diabetic Association which supports treating depression as it can
lead to better outcomes in patients with diabetes (Safren, et al., 2014). A consideration is that
depression may be due to a complex treatment regimen for the diabetes which should encourage
providers to simplify the management plan. The depression may not need to be treated with a
13
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medication, rather the treatment plan needs to be mutually designed so that it fits the patient’s
life.
The provider interview served to identify barriers to depression screening and treatment.
Although 70% (n=132) of the patients in this study were screened appropriately, responding
providers were in agreement that an EMR alert identifying the need for screening would be
helpful. This would be easy to implement and it would help ensure that all patients receive
depression screening. The barriers identified in response to treatment of depression include lack
of patient follow up and lack of access and financial means to obtain mental health services.
Only 19% of the patients diagnosed with depression in this study had received further mental
health services from a psychiatric specialist.
There was agreement among surveyed providers that an improved database of mental
health services would be helpful. Further, information should be made available regarding
associated costs and accepted insurance plans for mental health. Forging a stronger connection
between mental health services and primary care providers will improve patient care
tremendously. One aspect that may affect the efficacy of depression treatment in primary care is
that primary care providers have the added difficulty of managing multiple complex issues in a
shorter visit than mental health professionals. One trend is to embed psychiatric services within
primary care practices. Collaborative, in-office care with a psychiatric specialist, social worker,
or other allied health professional has been shown to be a cost-effective way to improve
outcomes and increase coordination between much needed community resources (Goodrich,
Kilbourne, Nord, & Bauer, 2013).
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Limitations
Several limitations will limit generalizability of these study findings. This was a single
practice location with a non-diverse sample and small group numbers. In addition, the extent of
the comorbidities was not examined. Each of these may have skewed the results. Further studies
with larger sample sizes could more confidently detect relationships between variables.
Data from the provider interviews were limited due to participation. Only half (3/6) of
the providers gave responses regarding depression screening. This limits the variety of responses
and makes the results less representative of all providers. There also may have been an element
of self-selection. The providers who participated may have more of an interest in depression.
There is also the limitation of biased response to surveys, wherein one may not respond honestly
and accurately or only give responses that show them in a more favorable manner.
Implications for Practice
While the importance of depression screening has been recognized, no current measures
or reminders are in place to ensure adequate screening by providers at the study location.
Implementation of an EMR alert prompting providers to screen for depression during annual
wellness exams would be beneficial. Studies indicate an increase in depression screening and
treatment through the use of EMR alerts (Matthews, 2017). Further, an EMR prompt could also
be put in place to prevent unnecessary rescreening.
Many of the providers listed time constraints as a barrier to screening. Enlisting the use
of the medical assistant for depression screening is tempting. Yet considering the sensitivity of
the questions, it may be beneficial for the medical assistant to use an electronic source for the
patient to self-screen. One idea is the use of an iPad where the survey results then populate into
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the EMR. This would allow the provider to quickly review the screening and determine if any
further inquiry is warranted.
Additional information about the patient’s depression and treatment needs to be added in
an easy to complete format within the EMR. This could be in the form of check boxes for key
points such as medication education and recommendations for mental health services. An
important recommendation is to provide available patient mental health resources within the
community. This could be recorded on a one page handout with phone numbers and insurance
preferences outlined along with copay information. In the spirit of the medical home, embedding
mental health services (i.e. mental health APRNs) within a primary care office offers
accessibility, convenience, increased coordination, and access to care- all known barriers for the
utilization of mental health services.
Recommendations for Future Studies
Further exploration of depression and the extent of the treatment plan within each
comorbidity should be conducted. It is possible that within each comorbidity depression is
associated with the complexity of the treatment plan. This would be vital not only for
identifying who may be at risk for depression, but also for simplifying the treatment plan.
Intrinsic to the problem are sociodemographic variables that were not considered in this
project. There may be an association between social support, income, and education that may
help to further identify those at risk for depression. Patient responses to evaluate their needs
regarding depression treatment must be considered.
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Conclusion
The goal of this study was to evaluate current rates of depression screening and treatment
in patients with comorbidities at a single primary care practice. A total of 70% of patients were
screened per guideline recommendations, all using the PHQ-2/9 tool. Although only one-third of
patients diagnosed with depression had documentation of treatment, improvement within the
EMR may capture the full extent of interventions. Improvement is needed in the areas of patient
education regarding medication side effects, timely follow-up, and increased collaboration with
mental health services. The new emphasis on patient medical homes tasks primary care
providers with the responsibility of attending to a patient’s holistic needs. Mental health services
are an integral part in this model of care delivery.
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Table 1
Inclusion Criteria List of ICD-10 Codes
ICD-10 Codes

Diagnosis Definition

E66.01

Morbid (severe) obesity due to excess calories

E66.09

Other obesity due to excess calories

E66.1

Drug-induced obesity

E66.3

Overweight

E66.8

Other obesity

E66.9

Obesity, unspecified

E11.9

Type 2 diabetes mellitus without complications

I10

Essential (primary) hypertension

J44.0

Chronic obstructive pulmonary disease with acute lower respiratory infection

J44.1

Chronic obstructive pulmonary disease with (acute) exacerbation

J44.9

Chronic obstructive pulmonary disease, unspecified
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Table 2
List of Variables per Category
Category

Variables/Measures

Age

Age of patient in years

Gender

0=male, 1=female

Ethnicity

0=white, 1=African American, 3=Hispanic, 4=Asian,
5=Other/Unknown

Family History of Depression

0=no, 1=yes

Patient Screened for Depression

0=no, 1=yes

Screening Tool Used

0=PHQ2/9, 1=other

Documented on Paper or EMR

0=Paper, 1=EMR

Patient diagnosed with depression 0=no, 1=yes
Length of depression diagnosis

Length in years patient has had depression

Severity of depression

0=mild, 1=moderate, 2=severe

On depression medications

0=no, 1=yes (medication listed)

Referred to further services

0=no, 1=yes (psych)

Follow specific to depression

0=no, 1=yes

Timely follow up

0=no, 1=yes

Meds adjusted or appropriate

0=no, 1=yes

dose documented
Medication side effects discussed

0=no, 1=yes

Other medications

List of patients other medications

Office visits in last 12 months

Total number of office visits in last 12 months

Other comorbidities

List of other patient diagnoses

Last 3 BMI’s

Last 3 body mass index readings in obese patients

Last 3 BP’s

Last 3 blood pressure readings in hypertensive patients

Last 3 A1C’s

Last 3 hemoglobin A1C readings in diabetic patients
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Table 3
Demographic and clinical characteristics of the study sample (N=188)
Mean (SD) or n (%)
Age

Mean 57.6 (14.9)

Gender

39.9% Male, 60.1% Female

Ethnicity

87.8% White, 10.1% African American, 0.5%
Asian, 0.5% Hispanic, 1% Unknown

Family History of Depression

10.1% Yes, 89.9% No

Patient Screened for Depression

70.2% Yes (62.2% within the last year, 8%
over one year ago), 29.8% No.

Tool Used for Screening

100% PHQ2/9

Notes: Standard Deviation (SD)
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Table 4
Associations between demographic and clinical characteristics and screening for depression.
Screened (n=), Mean Not screened (n=),

p-value

(SD) or %

Mean (SD) or %

Age

n=132, 59.7 (13.9)

n=56, 52.7 (16.0)

.003

Gender

n=132, 70.2%

n=56, 29.8%

.093

Ethnicity

n=131, 70.4%

n=55, 29.6%

.071

Family History of

n=132, 70.2%

n=56, 29.8%

0.657

By Diagnosis

COPD- n=28, 73.7% n=10, 26.3%

0.091

(COPD, Obese,

Obese- n=30, 60%

n=20, 40%

Obese/HTN,

Obese/HTN- n=41,

n=9, 18%

Obese/HTN/DM2)

82%

Depression

Obese/HTN/DM2-

n=17, 34%

n=33, 66%
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Table 5
Associations between those screened for depression based on depression diagnosis
Diagnosed with

No diagnosis of

depression n= (%)

depression n= (%)

<35yrs: 4 (6%)

12 (10%)

36-45yrs: 12 (18%)

12 (10%)

46-55yrs: 13 (19%)

23 (19%)

56-65yrs: 24 (36%)

30 (25%)

>65yrs: 14 (21%)

44 (36%)

Caucasian: 58 (90%)

107 (88%)

Af. Amer:6 (9%)

13 (11%)

Hispanic:1 (1%)

0 (0%)

Asian: 0 (0%)

1 (1%)

Family History of

Yes: 12 (18%)

Yes: 7 (6%)

depression

No: 55 (82%)

No: 114 (94%)

Gender

Female: 56 (84%)

Female: 57 (47%)

Male: 11(16%)

Male: 64 (54%)

7.6

0.3

Age By Groups

Ethnicity

Average PHQ-2/9

26

p-value

0.087

0.476

.017

.000

N/A
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Table 6
Clinical characteristics among those diagnosed with depression (N=67).
n (%)
Follow up depression specific

8 of 67 patients (11.9%)

Timely follow-up in accordance to guideline

32 of 67 patients (47.8%)

Meds adjusted or appropriate dose documented

27 of 67 patients (40.3%)

Side effects discussed/documented

9 of 67 patients (11.9%)

Referral to further mental health services

13 of 67 patients (19.4%)
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Table 7
Associations between clinical characteristics and diagnosis of depression/on depression
medications.
Diagnosis of

No diagnosis of

depression (n=),

depression

p-value

Mean (SD)
Obese (BMI)

n=54, 39.02 (9.02)

n=96, 38.08 (6.59)

.468

Hypertension (BP)

n=36, 128.94 (17.49)

n=64, 128.95 (15.26)

.998

Type 2 Diabetes

n=20, 6.5 (.78)

n=30, 7.87 (1.45)

.000

(A1C)

28

EVALUATION OF DEPRESSION SCREENING PRACTICES
Appendix
Primary Care Provider Questionnaire
1. Describe your standard routine for depression screening in adults.
2. Do you screen all adult patients? Why or why not?
3. Which of the various tools do you use to screen for depression?
4. Describe your standard routine for treatment and follow up of depression.
5. How often do you refer to psychiatry or other mental health services?
6. Do you feel you and your patients would benefit from an improved database of area mental
health services?
7. Do you feel there are any barriers preventing you or others from performing annual depression
screening in adult patients? What could reduce these barriers?
8. Do you feel it is easy to find and administer depression screening tools, like the PHQ-2 tool, in
EPIC?
9. Would an electronic medical record alert help you in recognizing annual depression screening
need for adult patients?
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